(Q45861560)

17 December 2017

title

Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12. (English)

1 reference

17 December 2017

author name string

Fuji N

1

1 reference

17 December 2017

Fujiwara H

2

1 reference

17 December 2017

Ueda Y

3

1 reference

17 December 2017

Taniguchi F

4

1 reference

17 December 2017

Yoshimura T

5

1 reference

17 December 2017

Oka T

6

1 reference

17 December 2017

Yamagishi H

7

1 reference

17 December 2017

publication date

1 June 1999

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

1120-1127

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3300916

exact match

0 references

cites work

Adenoviral thymidine kinase prodrug gene therapy inhibits sarcoma growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

21 January 2018

IL-12 at the crossroads.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Combination gene therapy for liver metastasis of colon carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Adeno-associated virus vectors preferentially transduce cells in S phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

On the mechanism of tumor ‘concomitant immunity’

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

Cancer vaccines: a road map for the next decade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

1 reference

7 January 2021

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

Details of an isolation method for hepatic lymphocytes in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300916

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3300916

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017